Liver Cancer/HCC
Liver Cancer/HCC
Antiviral Treatment for Hepatitis B Lowers Risk of Liver Cancer
- Details
- Category: HBV Treatment
- Published on Thursday, 19 June 2014 00:00
- Written by Liz Highleyman
Antiviral therapy for chronic hepatitis B virus (HBV) infection can reduce the risk of developing hepatocellular carcinoma (HCC), even among people with high HBV viral load, according to research described in the May 2014 edition of Clinical Gastroenterology and Hepatology.
EASL 2014: New Research Sheds Light on Liver Cancer Diagnosis, Staging, and Treatment
- Details
- Category: Liver Cancer/HCC
- Published on Monday, 14 April 2014 00:00
- Written by EASL
Dramatic regional differences in survival rates for people with hepatocellular carcinoma (HCC) are largely attributable to varying national policies regarding screening and treatment, according to study findings presented at the 49thEASL International Liver Congress last week in London. Related research showed that percutaneous radiofrequency ablation is effective for treating single liver cancer tumors.
ICAAC 2013: Liver Cancer Often Diagnosed Late with Poor Survival in People with HIV
- Details
- Category: Liver Cancer/HCC
- Published on Tuesday, 01 October 2013 00:00
- Written by Liz Highleyman
Hepatocellular carcinoma (HCC) is frequently diagnosed at an advanced stage in HIV positive people with hepatitis B or C coinfection, contributing to a high mortality rate that has changed little in recent years, according to a report at the recent 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2013) in Denver.
ILCA 2013: High HBV Viral Load Raises Risk of Progression to Liver Cancer
- Details
- Category: Liver Cancer/HCC
- Published on Friday, 04 October 2013 00:00
- Written by Liz Highleyman
Hepatitis B patients with high HBV DNA levels, indicating active viral replication, are more likely to experience progression of abnormal liver nodules to hepatocellular carcinoma, researchers reported at the 7th International Liver Cancer Association Annual Conference (ILCA 2013) last month in Washington, DC.
Hepatitis B Treatment with Entecavir Lowers Risk of Liver Cancer
- Details
- Category: HBV Treatment
- Published on Thursday, 01 August 2013 00:00
- Written by Liz Highleyman
Long-term treatment with entecavir (Baraclude) significantly reduces the chances of developing hepatocellular carcinoma compared with no treatment, and appears to lower the risk more than an older drug, especially for the most at-risk patients, according to a report in the July 2013 issue of Hepatology.
More Articles...
- EASL 2013: Long-term Tenofovir Reduces Liver Cancer Risk in People with Chronic Hepatitis B
- Heavy Alcohol Use Increases Liver Cancer Risk for People with Hepatitis B
- Liver Disease Is Leading Cause of Death for People with Chronic Hepatitis B
- AASLD 2012: Patients with Cirrhosis Can Respond Well to Boceprevir or Telaprevir with Careful Monitoring
Web Design and Development by